iShares Nasdaq Biotechnology ETF (IBB)

116.29
Delayed Data
As of Aug 17
 +0.02 / +0.02%
Today’s Change
100.22
Today|||52-Week Range
120.06
+8.92%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.

Health Care ETFs Outperforming: Will the Rally Last?
Aug 13 / Zacks.com - Paid Partner Content
Biotech ETFs in Focus on String of Q2 Earnings Beat
Aug 10 / Zacks.com - Paid Partner Content

Performance

1 month-1.75% 3 years-1.90%
3 months+8.17% 5 years+13.35%
1 year+14.79% Since inception+7.55%
Data through 08/18/2018

Quote Details

Previous close$116.27
Open day’s range115.40 – 116.62
Net asset value (NAV)116.24 (08/17/2018)
Daily volume1,498,282
Average volume (3 months)2,406,694
Data as of 4:00pm ET, 08/17/2018

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+13.35%+14.50%
Expense Gross exp ratio0.47%1.29%
Risk 5 year sharpe ratio0.620.91
Net assets$9.6B$3.3B
Average market cap$17.6B$28.1B
Average P/E30.228.8
Dividend / Share--0.31%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences8.63%
BIIB Biogen8.50%
AMGN Amgen8.18%
CELG Celgene7.91%
ILMN Illumina Inc5.78%
REGN Regeneron Pharmaceuticals4.58%
VRTX Vertex Pharmaceuticals Inc4.25%
ALXN Alexion Pharmaceuticals Inc3.67%
MYL Mylan NV2.38%
BMRN Biomarin Pharmaceutical Inc2.20%